ALSPW — Spineway SA Share News
0.000.00%
Last trade - 00:00- €4.37m
- €2.40m
- €12.43m
Brief: Spineway FY revenue down at 5.1 mln euros
Brief: Spineway signs new distribution agreement in Dallas
Brief: Spineway announces that TINAVI Medical Technologies has joined its capital
Brief: Spineway gets shareholders' approval on 1.4 million euro capital increase
Brief: Spineway H1 operating loss stable at 1.0 million euros
Brief: Spineway signs a partnership deal with TINAVI Medical Technologies
Brief: Spineway creation of a subsidiary of Spineway, signature of an important marketing agreement in USA initial order of 2 million $
Brief: Spineway receives new approvals from the FDA
Brief: Spineway H1 revenue down at 2.4 mln euros
Brief: Spineway confirms good results for new range of Mont Blanc MIS
Brief: Spineway FY net loss stable at EUR 1.7 mln
Brief: Spineway gets ptatents for Mont-Blanc 3D+ in USA and Europe
Brief: Spineway H2 revenue up 14.6% at 2.9 million euros
Brief: Spineway announces deals in Switzerland and Denmark
Brief: Spineway H1 net loss widens to 0.9 mln euros
Brief: Spineway gets homologation for three products in Australia
Brief: Spineway H1 revenue at EUR 2.8 mln, up 6.6%
Brief: Spineway announces successful trials for its new range Mont-Blanc minimally invasive
Brief: Spineway says FDA updates approvals for Mont-Blanc and Blue Mountain ranges